ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,911, issued on May 12, was assigned to CHILDREN'S HOSPITAL MEDICAL CENTER (Cincinnati).

"Methods and compositions for the treatment of pulmonary fibrosis using volasertib" was invented by Satish Kumar Madala (Cincinnati).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for treating an individual having, or at risk of having, pulmonary fibrosis, wherein volasertib, a salt thereof, or hydrate thereof, is administered to the individual in need thereof. In one aspect, the pulmonary fibrosis may be idiopathic pulmonary fibrosis. The volasertib may be administered in an amount and for a duration of time effective to achieve one or...